Résumé
Les lymphomes intestinaux sont des lymphomes non-hodgkiniens (LNH), moins fréquents que les lymphomes gastriques et aussi issus du tissu lymphoïde associé aux muqueuses (Mucosa Associated Lymphoid Tissue = MALT), normalement présent au niveau de l’intestin grêle et du colon. Ils regroupent différentes entités anatomocliniques qu’il convient de bien connaître car leur origine cellulaire et leur présentation clinique conditionnent leur évolution et leur traitement. Ces dernières années, une meilleure description des profils immuno-histochimiques et des différentes anomalies moléculaires de ces lymphomes, ont contribué à l’amélioration des outils diagnostiques et thérapeutiques et à leur meilleure prise en charge.
La maladie des chaînes lourdes alpha, parmi les lymphomes dits autrefois méditerranéens, représente une forme variante des lymphomes du MALT digestif, qui n’est pratiquement plus rencontrée en Europe, et ne sera pas traitée dans cette revue.
Abstract
Non-Hodgkin intestinal lymphomas are less frequently observed than gastric lymphomas, but also derive from the mucosa-associated lymphoid tissue (MALT) present in a normal intestine. They comprise different clinical and histological entities which should be well defined since their treatment and prognosis will depend on their histological and clinical features. The recent advances in our understanding of immuno-histochemical profiles and different molecular abnormalities of these lymphomas, have contributed to their better diagnosis and clinical management.
The alpha-heavy chain disease, known as Mediterranean lymphoma, which represents another variety of digestive MALT lymphoma, very rarely observed in Europe, will not be addressed in this review.
Références
Otter R, Bieger R, Kluin PM, et al (1989) Primary gastrointestinal non-Hodgkin’s lymphoma in a population-based registry. Br J Cancer 60:745–750
Capelle LG, de Vries AC, Looman CW, et al (2008) Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 44:2470–2476
d’Amore F, Christensen BE, Brincker H, et al (1991) Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 27:1201–1208
Ullrich A, Fischbach W, Blettner M. (2002) Incidence of gastric B-cell lymphomas: a population-based study in Germany. Ann Oncol 13:1120–1127
Andrews CN, John Gill M, Urbanski SJ, et al (2008) Changing epidemiology and risk factors for gastrointestinal non-Hodgkin’s lymphoma in a North American population: population-based study. Am J Gastroenterol 103:1762–1769
Ducreux M, Boutron MC, Piard F, et al (1998) A 15-year series of gastrointestinal non-Hodgkin’s lymphomas: a populationbased study. Br J Cancer 77:511–514
Gurney KA, Cartwright RA, Gilman EA. (1999) Descriptive epidemiology of gastrointestinal non-Hodgkin’s lymphoma in a population-based registry. Br J Cancer 9:1929–1934
Ruskone-Fourmestraux A, Rambaud JC. (2001) Gastrointestinal lymphoma: prevention and treatment of early lesions. Baillieres Best Pract Res Clin Gastroenterol 15:337–354
Matuchansky C, Touchard G, Lemaire M, et al (1985) Malignant lymphoma of the small bowel associated with diffuse nodular lymphoid hyperplasia. N Engl J Med 313:166–171
Heise W. (2010) GI-lymphomas in immunosuppressed patients (organ transplantation; HIV). Best Pract Res Clin Gastroenterol 24:57–69
Heise W, Arasteh K, Mostertz P, et al (1997) Malignant gastrointestinal lymphomas in patients with AIDS. Digestion 58:218–224.
Bergeron V, Vienne A, Sokol H, et al (2010) Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis. Am J Gastroenterol 105:2405–2411
Sokol H, Beaugerie L, Maynadie M, et al (2012) Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease. Inflamm Bowel Dis 18:2063–2071
Cellier C, Delabesse E, Helmer C, et al (2000) Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 356:203–208
Malamut G, Afchain P, Verkarre V, et al (2009) Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136:81–90
Isaacson PG, Spencer J, Wright DH. (1988) Classifying primary gut lymphomas. Lancet 2:1148–1149
Du MQ. (2007) MALT lymphoma: recent advances in aetiology and molecular genetics. J Clin Exp Hematop 7:31–42
Swerdlow SH, Campo E, Seto M, Muller-Hermelink HK. (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. In: Swerdlow SH, editor. Lyon: IARC p 229–232
Ruskone-Fourmestraux A, Aegerter P, Delmer A, et al (1993) Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d’Etude des Lymphomes Digestifs. Gastroenterology 105:1662–1671
Matysiak-Budnik T, Jamet P, Fabiani B, et al (2013) Primary intestinal B-cell lymphoma: A prospective multicentre clinical studyof 91 cases. Dig Liv Dis 45:947–952
Nakamura S, Matsumoto T, Iida M, et al (2003) Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 97:2462–2473
Li B, Shi YK, He XH, et al (2008) Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients. Int J Hematol 87:375–381
Fischbach W, Kestel W, Kirchner T, et al (1992) Malignant lymphomas of the upper gastrointestinal tract. Results of a prospective study in 103 patients. Cancer 70:1075–1080
Daum S, Ullrich R, Heise W, et al (2003) Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. J Clin Oncol 21:2740–2746
Kim SJ, Choi CW, Mun YC, et al (2011) Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC Cancer 11:321
Nakamura S, Matsumoto T, Takeshita M, et al (2000) A clinicopathologic study of primary small intestine lymphoma: prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. Cancer 88:286–294
Raderer M, Chott A, Drach J, et al (2002) Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary? Ann Oncol 13:1094–1098
Ruskone-Fourmestraux A, Delmer A, Lavergne A, et al (1997) Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D’etude des Lymphomes Digestifs. Gastroenterology 112:7–16
Ruskone-Fourmestraux A, Audouin J. (2010) Primary gastrointestinal tract mantle cell lymphoma as multiple lymphomatous polyposis. Best Pract Res Clin Gastroenterol 24:35–42
Kluin-Nelemans HC, Doorduijn JK. (2011) Treatment of elderly patients with mantle cell lymphoma. Semin Hematol 48:208–213
Damaj G, Verkarre V, Delmer A, et al (2003) Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann Oncol 14:623–629
Patte C, Ribrag V, Brugieres L. (2007) Non Hodgkin’s lymphoma in adolescents. Bull Cancer 94:339–348
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Matysiak-Budnik, T., Ruskoné-Fourmestraux, A. Les lymphomes de l’intestin grêle. Colon Rectum 8, 19–24 (2014). https://doi.org/10.1007/s11725-014-0512-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11725-014-0512-z